Asian Phytoceuticals PCL Balance Sheet

Financials in millions THB. Fiscal year is January - December.

Millions THB. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	128.34	102.51	62.37	125.63	82.15	98.59
Short-Term Investments	257.22	38.36	76.37	102.01	61.25	32.23
Trading Asset Securities	-	218.82	212.92	23.54	35.75	36.09
Cash & Short-Term Investments	385.56	359.69	351.66	251.19	179.15	166.92
Cash Growth	11.59%	2.28%	40.00%	40.21%	7.33%	-2.98%
Accounts Receivable	2.86	2.58	3.38	0.89	0.98	0.54
Other Receivables	1.38	1.18	2.11	3.34	3.23	2.74
Receivables	4.24	3.77	5.49	4.22	4.21	3.29
Inventory	72.64	69.07	57.03	44.27	52.88	59.94
Prepaid Expenses	1.18	0.9	1.14	0.9	0.92	0.67
Other Current Assets	0.27	4.55	0.2	0.23	0.35	0.3
Total Current Assets	463.88	437.97	415.53	300.82	237.51	231.11
Property, Plant & Equipment	42.7	47.97	66.44	82.34	64.02	91.21
Long-Term Investments	124.03	123.84	136.11	303.86	365.01	346.73
Other Intangible Assets	0.62	0.64	0.61	0.79	0.24	0.36
Long-Term Deferred Tax Assets	11.32	11.16	11.18	10.75	7.11	5.05
Other Long-Term Assets	6.16	6.16	6.14	6.17	6.25	6.07
Total Assets	648.72	627.74	636.02	704.72	680.15	680.53
Accounts Payable	1.81	1.01	0.77	1.2	0.64	1.99
Accrued Expenses	16.26	14.93	16.08	16.47	14.46	14.07
Current Portion of Leases	8.7	11.87	13.2	13.45	12.2	18.74
Current Income Taxes Payable	12.7	8.14	5.2	10.77	12.7	9.64
Current Unearned Revenue	0.26	0.36	0.29	0.26	0.31	0.32
Other Current Liabilities	3.15	4.04	3.12	4.05	4.78	2.99
Total Current Liabilities	42.88	40.36	38.64	46.2	45.1	47.75
Long-Term Leases	1.23	1.79	10.91	22.22	1.62	15.49
Pension & Post-Retirement Benefits	21.76	21.36	22.71	19.88	18.89	17.29
Other Long-Term Liabilities	4.04	4.04	4.04	4.04	4.04	5.01
Total Liabilities	69.91	67.54	76.3	92.34	69.64	85.54
Common Stock	300	300	300	300	300	300
Additional Paid-In Capital	166.94	166.94	166.94	166.94	166.94	166.94
Retained Earnings	126.87	109.31	109.06	161.63	146.3	126.75
Comprehensive Income & Other	-18.56	-19.29	-19.18	-18.88	-5.27	1.3
Total Common Equity	575.25	556.96	556.82	609.7	607.98	594.99
Minority Interest	3.56	3.23	2.89	2.69	2.53	-
Shareholders' Equity	578.81	560.19	559.72	612.39	610.51	594.99
Total Liabilities & Equity	648.72	627.74	636.02	704.72	680.15	680.53
Total Debt	9.93	13.66	24.11	35.67	13.82	34.23
Net Cash (Debt)	375.63	346.03	327.56	215.52	165.33	132.69
Net Cash Growth	17.02%	5.64%	51.99%	30.36%	24.60%	8.74%
Net Cash Per Share	0.62	0.56	0.54	0.36	0.28	0.22
Filing Date Shares Outstanding	600	600	600	600	600	600
Total Common Shares Outstanding	600	600	600	600	600	600
Working Capital	421.01	397.61	376.88	254.62	192.42	183.36
Book Value Per Share	0.96	0.93	0.93	1.02	1.01	0.99
Tangible Book Value	574.63	556.32	556.22	608.91	607.74	594.64
Tangible Book Value Per Share	0.96	0.93	0.93	1.01	1.01	0.99
Land	-	7.67	8.29	8.29	8.29	8.29
Buildings	-	78.05	90.24	93.72	91.07	91.04
Machinery	-	82.61	82.06	82.71	82.49	82.74